Literature DB >> 1695471

Role of phospholipase A2 and G-proteins in the IgE-dependent activation of mast cells and macrophages.

C Bronner1, V Cothenet, D Monté, M Joseph, Y Landry, A Capron.   

Abstract

The effect of para-bromophenacyl bromide (a selective inhibitor of phospholipase A2) and pertussis toxin has been investigated on IgE-dependent histamine release and on IgE-dependent macrophage-mediated cytotoxicity. Para-bromophenacyl bromide inhibited dose-dependently IgE-dependent stimulation of mast cells and macrophages (IC50's of 5.0 X 10(-7) M and 2.5 X 10(-7) M, respectively). In contrast, pertussis toxin only inhibited the IgE-dependent stimulation of macrophages, whereas the IgE-dependent activation of mast cells was not affected. These results suggest that the transducing mechanisms following the activation of the high affinity receptor for IgE (Fc epsilon RI on mast cells) as well as the low affinity receptor for IgE (Fc epsilon RII on macrophages) induce the activation of phospholipase A2. Fc epsilon RII might be coupled to a pertussis toxin sensitive G-protein.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1695471     DOI: 10.1007/bf01969008

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  10 in total

1.  Complete structure and expression in transfected cells of high affinity IgE receptor.

Authors:  U Blank; C Ra; L Miller; K White; H Metzger; J P Kinet
Journal:  Nature       Date:  1989-01-12       Impact factor: 49.962

2.  Simultaneous inhibitions of inositol phospholipid breakdown, arachidonic acid release, and histamine secretion in mast cells by islet-activating protein, pertussis toxin. A possible involvement of the toxin-specific substrate in the Ca2+-mobilizing receptor-mediated biosignaling system.

Authors:  T Nakamura; M Ui
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

3.  From parasites to allergy: a second receptor for IgE.

Authors:  A Capron; J P Dessaint; M Capron; M Joseph; J C Ameisen; A B Tonnel
Journal:  Immunol Today       Date:  1986-01

Review 4.  Receptor-mediated activation of phospholipase A2 via GTP-binding proteins: arachidonic acid and its metabolites as second messengers.

Authors:  J Axelrod; R M Burch; C L Jelsema
Journal:  Trends Neurosci       Date:  1988-03       Impact factor: 13.837

5.  Biochemical analysis of triggering signals induced by bridging of IgE receptors.

Authors:  T Ishizaka
Journal:  Fed Proc       Date:  1982-01

6.  Activation of rat peritoneal mast cells by substance P and mastoparan.

Authors:  M Mousli; C Bronner; J L Bueb; E Tschirhart; J P Gies; Y Landry
Journal:  J Pharmacol Exp Ther       Date:  1989-07       Impact factor: 4.030

7.  Polyphosphoinositide turnover in rat mast cells stimulated by antigen: rapid and preferential breakdown of phosphatidylinositol 4-phosphate (DPI).

Authors:  Y Ishizuka; A Imai; Y Nozawa
Journal:  Biochem Biophys Res Commun       Date:  1984-09-28       Impact factor: 3.575

8.  A major role for phospholipase A2 in antigen-induced arachidonic acid release in rat mast cells.

Authors:  K Yamada; Y Okano; K Miura; Y Nozawa
Journal:  Biochem J       Date:  1987-10-01       Impact factor: 3.857

9.  Inhibition of histamine secretion from rat peritoneal mast cells and rabbit leukocytes by p-bromophenacyl bromide, a phospholipase A2 inhibitor.

Authors:  N Chand; J Pillar; W Diamantis; R D Sofia
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1987-01

10.  Two G-proteins act in series to control stimulus-secretion coupling in mast cells: use of neomycin to distinguish between G-proteins controlling polyphosphoinositide phosphodiesterase and exocytosis.

Authors:  S Cockcroft; T W Howell; B D Gomperts
Journal:  J Cell Biol       Date:  1987-12       Impact factor: 10.539

  10 in total
  1 in total

1.  The receptor mechanism mediating the contractile response to adenosine on lung parenchymal strips from actively sensitised, allergen-challenged Brown Norway rats.

Authors:  Cedric Wolber; John R Fozard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-01-27       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.